Value Bridge — LEWIS GALE MEDICAL CENTER
Current $55M → Target $64M (+$9.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$54.8M
Current EBITDA
$63.7M
Target EBITDA
+$9.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.0M
Payer Mix Optimization
$4.9M
Cost to Collect Reduction
$1.6M
Clean Claim Improvement
$1.2M
Volume & Rate Growth
$8.1M
What This Means
The 7-lever model projects a 16% EBITDA uplift from $55M to $64M. The highest-impact lever is Volume & Rate Growth at $3.2M probability-weighted.
IC talking point: "We see $9M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $98M in equity value creation."